"10.1371_journal.pone.0018207","plos one","2011-03-31T00:00:00Z","Jennifer D Watkins; Nagadenahalli B Siddappa; Samir K Lakhashe; Michael Humbert; Anton Sholukh; Girish Hemashettar; Yin Ling Wong; John K Yoon; Wendy Wang; Francis J Novembre; Francois Villinger; Chris Ibegbu; Kalpana Patel; Davide Corti; Gloria Agatic; Fabrizia Vanzetta; Siro Bianchi; Jonathan L Heeney; Federica Sallusto; Antonio Lanzavecchia; Ruth M Ruprecht","Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, United States of America; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, United States of America; Humabs SAGL, Bellinzona, Switzerland; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; Institute for Research in Biomedicine, Bellinzona, Switzerland","Conceived and designed the experiments: DC AL RMR. Performed the experiments: JDW NBS SKL MH AS GH YLW JKY WW CI KP GA FV SB. Analyzed the data: JDW NBS SKL MH AS GH YLW JKY WW DC JLH FS AL RMR. Wrote the paper: JDW RMR. Managed primate experiments: FJN FV.","A. Lanzavecchia is the scientific founder of Humabs LLC, a company that develops human antibodies for treatment of infectious diseases. D. Corti, G. Agatic, F. Vanzetta and S. Bianchi are currently employees of Humabs. A. Lanzavecchia and F. Sallusto hold shares in Humabs. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","03","Jennifer D Watkins","JDW",21,TRUE,3,14,14,2,TRUE,TRUE,FALSE,0,NA,FALSE
